Recursion Pharmaceuticals, Inc. (RXRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-354,112
-328,066
-239,476
-186,479
-87,006
-
Depreciation & amortisation
28,051
24,402
11,756
8,405
3,943
-
Stock-based compensation
60,816
53,503
27,909
14,842
4,292
-
Change in working capital
-62,304
-50,257
104,921
-306
30,834
-
Accounts receivable
-
-
-
114
-5
-27
Accounts payable
520
-987
1,767
1,745
-185
-
Other working capital
-330,629
-300,332
-120,883
-198,412
-52,134
-
Other non-cash items
10,658
11,450
8,560
4,097
781
-
Net cash provided by operating activities
-316,764
-287,780
-83,524
-158,614
-45,399
-
Cash flows from investing activities
Investments in property, plant and equipment
-13,865
-12,552
-37,359
-39,798
-6,735
-
Acquisitions, net
-
-
0
0
-2,600
0
Purchases of investments
-
0
0
-301,137
0
-
Sales/maturities of investments
-
480
230,608
69,191
0
-
Other investing activities
-
-
-
-
595
-
Net cash used for investing activities
-11,541
-10,228
193,249
-271,744
-8,740
-
Cash flows from financing activities
Debt repayment
-768
-766
-90
-12,798
-77
-
Common stock issued
138,966
128,093
143,711
462,901
0
-
Other financing activities
-
-
-
-
6,400
-275
Net cash used provided by (used for) financing activities
152,108
140,133
154,345
458,540
246,135
-
Net change in cash
-176,226
-157,687
263,763
28,182
191,996
-
Cash at beginning of period
482,376
559,112
295,349
267,167
75,171
-
Cash at end of period
306,179
401,425
559,112
295,349
267,167
-
Free cash flow
Operating cash flow
-316,764
-287,780
-83,524
-158,614
-45,399
-
Capital expenditure
-13,865
-12,552
-37,359
-39,798
-6,735
-
Free cash flow
-330,629
-300,332
-120,883
-198,412
-52,134
-
© 2024 Yahoo. All rights reserved.